Business Wire

THALES

23.5.2024 09:01:29 CEST | Business Wire | Press release

Share
Thales Leads Innovative Digital Transformation of the Mauritius National Identity System

The Mauritius Prime Minister's Office (PMO) has entrusted the consortium led by Thales, which includes the leading Mauritian-grown IT provider Harel Mallac Technologies (HMT), with a crucial step toward developing a comprehensive National ID system to improve citizen services and bolstering identity security. This partnership sets the foundations for the next generation digital journey of Mauritius, fully aligned with the country’s 2030 digital strategy.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240523106005/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

©Thales

This ambitious modernisation effort draws on Thales experience from 300 government projects worldwide, and ensures that field-proven technology can be associated for timely delivery and reliable project execution. It is a long-term partnership providing consistent and expert support in all key components of the identity scheme, from citizen enrolment to physical and digital ID issuance. This end-to-end approach effectively meets future evolutions as well as potential identity threats.

As part of the 10-year contract Thales is providing a powerful and modular Identity Management System to securely issue cutting-edge eID cards and its mobile companion, the Digital ID Wallet. The solution assures comprehensive trust and privacy in daily interactions between public entities and individuals. The user experience is at the core of this modernisation drive, illustrated by the wider range of new functionalities and services it brings to citizens.

The citizen’s journey starts with a frictionless enrolment process, which can be initiated online from the comfort of home to save citizens time when visiting the enrolment centre. Once enrolled, the holder will receive a new eID card which relies on the latest Thales embedded software and advanced security features, including high resolution colour photo1, to effectively combat forgery and identity theft. For more convenience, self-service kiosks will be installed at dedicated spots to enable users to update their ID cards’ information (with new address, etc) and manage the PIN code associated with the digital certificates stored in their card.

Citizens can also activate their Digital ID Wallet, a secure mobile application where they can securely store and share digital identity documents. The wallet will initially include digital versions of the identity card and will subsequently contain other official documents such as birth and marriage certificates. These may then be shared both online and in-person. Citizens will also be able to digitally sign documents with a one-time certificate as well as log in to online government services by using their digital wallet. For service providers (public administrations, banks, retailers, universities, etc…) it will be a simpler and more secure way to verify identities. Citizens’ control over their personal data is guaranteed thanks to stringent data privacy and consent management mechanisms.

Mauritius identity cards production will benefit from Thales factories’ sustainability action plan, which aims to reduce the carbon footprint by utilising 100% renewable electricity, optimising energy consumption and minimising waste. As a complement to this approach, the Mauritius project is part of Thales' offsetting program which supports sustainable initiatives2 worldwide (selected in collaboration with Climate Impact Partner) by offsetting the carbon emissions from all its travel and ID solutions.

During the official launching on 26th February 2024 of the national ID card at the Sir Harilal Vaghjee Memorial Hall, Government Centre, Port Louis, it was stated that:
“The purpose of modernising the present system with sophisticated and next generation technology is to enable new services while increasing citizen security and convenience. The next-generation ID system will lay the foundation for supporting the country's digital transformation, benefiting all stakeholders and fostering economic growth.”

“With this implementation, blending ID cards and digital identity, Mauritius fully leverages the best of both worlds, offering the optimal combination of security and ease,” says Youzec Kurp, VP Identity and Biometrics Solutions at Thales. “The new Mauritius ID system stands as one of the most advanced and marks the first implementation of a fully interoperable Digital ID Wallet in Africa, adhering to international ISO standards. This positions Mauritius amongst the pioneer countries in identity solutions worldwide.”

1 The new e-document incorporates latest generation of embedded software together with advanced physical features such as Thales Colour Laser Shield technology (high resolution colour portrait) ensuring state-of-the-art protection against counterfeiting for both blank and personalised documents, True Vision (high resolution true-colour UV picture), transparent window element with the holders’ ghost image, and Secure Surface 3D tactile features combining movement and light reflection.
2 Example of supported projects in 2023: Vichada Afforestation in Colombia, Aqua Clara Water Filters in Kenya, Renewable Energy Portfolio worldwide.

About Thales

Thales (Euronext Paris: HO) is a global leader in advanced technologies specialized in three business domains: Defence & Security, Aeronautics & Space, and Cybersecurity & Digital identity.

It develops products and solutions that help make the world safer, greener and more inclusive.

The Group invests close to €4 billion a year in Research & Development, particularly in key innovation areas such as AI, cybersecurity, quantum technologies, cloud technologies and 6G.

Thales has close to 81,000* employees in 68 countries. In 2023, the Group generated sales of €18.4 billion.

* These figures exclude the ground transportation business, which is being divested.

PLEASE VISIT

Thales Group
Digital Identity & Security

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240523106005/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces Positive CHMP Opinion for Opzelura® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 13:30:00 CEST | Press release

If approved, Opzelura® (ruxolitinib) cream will be the first steroid-free, topical JAK treatment option in the European Union (EU) for adults with moderate atopic dermatitis (AD) for whom standard topical therapies have failedAD, the most common type of eczema which affects 230 million people globally,1 is a chronic, recurring, inflammatory and highly pruritic (itchy) skin condition that can have a significant impact on daily life2Phase 3 TRuE‑AD4 data supporting the positive CHMP opinion demonstrated that ruxolitinib cream met both co‑primary endpoints at Week 8, maintained disease control with as-needed treatment through Week 24 and was well tolerated3,4,5 Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids

Datroway® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 13:00:00 CEST | Press release

Recommendation based on TROPION-Breast02 phase 3 trial where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival If approved, Datroway has potential to be the first TROP2 directed antibody drug conjugate for patients in EU with a demonstrated overall survival benefit as first-line treatment Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use

DAYBU®(trofinetide) Recommended for Approval in the European Union by CHMP26.6.2026 12:49:00 CEST | Press release

-- European Commission decision expected in the coming months-- If approved, DAYBU®would become the first treatment for neurobehavioral symptoms of Rett syndrome in the European Union Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re-examination procedure, recommending the granting of a marketing authorization for DAYBU® (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older. If granted marketing authorization by the European Commission, DAYBU® would be the first therapy approved for this indication in the European Union (EU). “The CHMP’s positive opinion for DAYBU® is an important milestone in our mission to bring this innovative therapy to the EU, where there are no therapies specifically approved for the neurobehavioral symptoms of this devastating

HTEC Showcases Lakebase Branching at Databricks’ Data & AI Summit26.6.2026 11:18:00 CEST | Press release

HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. The Solution was developed in collaboration with a leading risk and compliance technology provider who serves financial institutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260626875859/en/ HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. Solving Critical Development Bottlenecks in Regulated Environments At the core of the collaboration was a shared challenge: how to enable modern data workflows in an envi

Stallergenes Greer Named One of Switzerland’s Best Managed Companies for 202626.6.2026 10:28:00 CEST | Press release

Stallergenes Greer, a global leader in allergy care, has been recognised for its overall business performance, company culture, and sustained growth by receiving the prestigious 2026 Switzerland’s Best Managed Companies award. The 2026 Best Managed Companies programme award winners are among Switzerland’s best private companies. The awards are derived from Deloitte’s global Best Managed Companies awards programme, an internationally recognised programme that evaluates businesses based on their leadership in the areas of strategy, culture and commitment, capabilities, innovation, governance and financial performance. Applicants are evaluated by an independent jury of experts. The evaluation of the Switzerland awards is based on more than 30 years of observed practice from the global awards programme that has been rolled out in 50+ countries worldwide. This recognition reflects Stallergenes Greer's consistent ability to deliver on its strategic vision while maintaining the operational di

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye